Pharmacovigilance Market - Global Industry Analysis
Pharmacovigilance Market by Clinical Trial Phase (Pre-Clinical, Phase 1, Phase 2, Phase 3, and Phase 4), by Service Provider (In-House and Contract Outsourcing), by Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining), and by End-User (Hospitals, Research Organizations, and Industries): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025
Published Date: 20-May-2019Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-1418
Status : Published
Global pharmacovigilance market expected to generate around USD 8.33 billion by 2025, at a CAGR of around 11.6% between 2019 and 2025. The global pharmacovigilance market is driven by the rising awareness about the safety and efficacy of drugs among the worldwide population and the growing demand for substantially adopting safe medical practices.